Clinical Trial Update: Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating sorafenib tosylate in combination with temsirolimus in adults with recurrent glioblastoma and gliosarcoma has completed, with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Gliosarcoma

Drugs mentioned

• Sorafenib tosylate (sorafenib tosylate)
• Temsirolimus (temsirolimus)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Glioblastoma, Adult Gliosarcoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-06-02